Leerink Partnrs Expects Weaker Earnings for Elevance Health

Elevance Health, Inc. (NYSE:ELV) – Research analysts at Leerink Partnrs decreased their Q3 2025 earnings per share (EPS) estimates for shares of Elevance Health in a note issued to investors on Thursday, January 23rd. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $9.36 per share for the quarter, down from their prior forecast of $9.66. The consensus estimate for Elevance Health’s current full-year earnings is $32.95 per share. Leerink Partnrs also issued estimates for Elevance Health’s FY2025 earnings at $34.31 EPS and Q1 2026 earnings at $12.65 EPS.

Elevance Health (NYSE:ELV) last released its quarterly earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a return on equity of 19.56% and a net margin of 3.68%.

Several other research analysts also recently weighed in on ELV. TD Cowen dropped their price target on Elevance Health from $589.00 to $484.00 and set a “buy” rating for the company in a research note on Monday, October 21st. Argus downgraded Elevance Health from a “buy” rating to a “hold” rating in a research note on Friday, October 18th. Raymond James set a $485.00 price objective on Elevance Health in a report on Friday, October 18th. Wells Fargo & Company decreased their price objective on Elevance Health from $593.00 to $495.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Finally, UBS Group decreased their price objective on Elevance Health from $605.00 to $555.00 and set a “buy” rating on the stock in a report on Friday, October 18th. Four equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $525.60.

Elevance Health Trading Up 2.5 %

ELV stock opened at $411.14 on Monday. Elevance Health has a 1-year low of $362.21 and a 1-year high of $567.26. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.50 and a quick ratio of 1.50. The company has a market capitalization of $95.35 billion, a price-to-earnings ratio of 14.99, a PEG ratio of 1.11 and a beta of 0.84. The business has a 50 day simple moving average of $386.21 and a two-hundred day simple moving average of $461.36.

Elevance Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Monday, March 10th will be paid a $1.71 dividend. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. The ex-dividend date is Monday, March 10th. This represents a $6.84 dividend on an annualized basis and a yield of 1.66%. Elevance Health’s dividend payout ratio (DPR) is presently 23.77%.

Institutional Trading of Elevance Health

A number of hedge funds and other institutional investors have recently bought and sold shares of ELV. Consolidated Portfolio Review Corp bought a new position in shares of Elevance Health during the 4th quarter worth $219,000. Rik Saylor Financial Inc. bought a new position in shares of Elevance Health during the 4th quarter worth $225,000. Money Concepts Capital Corp grew its position in shares of Elevance Health by 9.0% during the 4th quarter. Money Concepts Capital Corp now owns 1,764 shares of the company’s stock worth $651,000 after buying an additional 146 shares in the last quarter. Tranquilli Financial Advisor LLC grew its position in shares of Elevance Health by 14.1% during the 4th quarter. Tranquilli Financial Advisor LLC now owns 1,387 shares of the company’s stock worth $512,000 after buying an additional 171 shares in the last quarter. Finally, E. Ohman J or Asset Management AB grew its position in shares of Elevance Health by 11.1% during the 4th quarter. E. Ohman J or Asset Management AB now owns 10,440 shares of the company’s stock worth $3,851,000 after buying an additional 1,040 shares in the last quarter. Hedge funds and other institutional investors own 89.24% of the company’s stock.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.